Professional Publications

Provaznikova, D.; Rittich, S.; Malina, M.; Seeman, T.; Marinov, I.; Riedl, M.; Hrachovinova, I.

Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.

[year of publication 2011, impact factor 2.939 ]

Marinov, I.; Illingworth, A.J.; Benko, M.; Sutherland, D.R.

Performance characteristics of a non-fluorescent aerolysin-based paroxysmal nocturnal hemoglobinuria (PNH) assay for simultaneous evaluation of PNH neutrophils and PNH monocytes by flow cytometry, following published PNH guidelines

[year of publication 2016, impact factor 2.938 ]

Sutherland, D.R.; Ortiz, F.; Quest, G.; Illingworth, A.; Benko, M.; Nayyar, R.; Marinov, I.

High-sensitivity 5-, 6-, and 7-color PNH WBC assays for both Canto II and Navios platforms

[year of publication 2018, impact factor 2.938 ]

Sutherland, D.R.; Illingworth, A.; Marinov, I.; et al.

ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2: reagent selection and assay optimization for high-sensitivity testing

[year of publication 2018, impact factor 2.938 ]

Kuželová, K.; Grebeňová, D.; Pluskalová, M.; Kavan, D.; Halada, P.; Hrkal, Z.

Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells

[year of publication 2009, impact factor 2.935]

Petráčková, M.; Lučanský, V.; Vonka, V.

Tumor protective activity of CD4+ but not of CD8+ T cells in DNA-vaccinated mice challenged with bcr-abl-transformed cells

[year of publication 2013, impact factor 2.934 ]

Whiteside, S.; Markova, M.; Chin, A.; Lam, C.; Dharmani-Khan, P.; Modi, M.; Khan, F.; Storek, J.

Influence of chemotherapy on allergen-specific IgE

[year of publication 2018, impact factor 2.932 ]

Indrová, M.; Bubeník, J.; Mikyšková, R.; Vonka, V.; Šmahel, M.; Žák, R.; Šímová, J.; Bieblová, J.; Mendoza, L.; Jandlová, T.

Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin

[year of publication 2006, impact factor 2.931]

Reicheltová, Z.; Májek, P.; Riedel, T.; Suttnar, J.; Dyr, J.E.

Simplified platelet sample preparation for SDS-PAGE-based proteomic studies

[year of publication 2012, impact factor 2.925 ]

Šárová, I.; Březinová, J.; Zemanová, Z.; Gančarčíková, M.; Vydra, J.; Čermák, J.; Michalová, K.

A novel gene LRP5 on 11q13.2 is rearranged in two patients with acute myeloid leukemia

[year of publication 2011, impact factor 2.923 ]

Moravcová, J.; Rulcová-Karavdić, J.; Broučková, A.; Klamová, H.

Effect of the duration and quality of peripheral blood sample storage on the results of qualitative and quantitative BCR-ABL transcript analyses in patients with CML

[year of publication 2011, impact factor 2.923 ]

Lopotová, T.; Žáčková, M.; Klamová, H.; Moravcová, J.

MicroRNA-451 in chronic myeloid leukemia: miR-451–BCR-ABL regulatory loop?

[year of publication 2011, impact factor 2.923 ]

Kvasnička, J.; Marek, J.; Kvasnička, T.; Weiss, V.; Marková, M.; Štěpán, J.; Umlaufová, A.

Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement

[year of publication 2006, impact factor 2.922]

Giebel, S.; Labopin, M.; Holowiecki, J.; Labar, B.; Komarnicki, M.; Koza, V.; Masszi, T.; Mistrik, M.; Lange, A.; Hellmann, A.; Vitek, A.; Pretnar, J.; Mayer, J.; Rzepecki, P.; Indrak, K.; Wiktor-Jedrzejczak, W.; Wojnar, J.; Krawczyk-Kulis, M.; Kyrcz-Krzemien, S.; Rocha, V.

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers : better results in recent years

[year of publication 2009, impact factor 2.919]

Shearer, M.; Bartkova, J.; Bartek, J.; Berdichevsky, F.; Barnes, D.; Millis, R.; Taylor-Papadimitriou, J.

Studies of clonal cell lines developed from primary breast cancers indicate that the ability to udergo morphogenesis in vitro is lost early in malignancy

[year of publication 2006, impact factor 2.917]

Suchánková, A.; Krčmář, M.; Krchňák, V.; Hamšíková, E.; Kaňka, J.; Vágner, J.; Vonka, V.

Range of HPV 16 E7 antibodies in cervical cancer patients and healthy subjects

[year of publication 2006, impact factor 2.917]

Asp, J.; Skov, V.; Bellosillo, B.; Kristensen, T.; Lippert, E.; Dicker, F.; Schwarz, J.; et al.

International external quality assurance of JAK2 V617F quantification

[year of publication 2018, impact factor 2.904 ]

Klener, P.Jr.; Leahomschi, S.; Molinsky, J.; Simonova, T.; Necas, E.; Gasova, Z.; Cermak, J.; Dolezalova, L.; Andera, L.; Zivny, J.

TRAIL-induced apoptosis of HL60 leukemia cells : two distinct phenotypes of acquired TRAIL resistance that are accompanied with resistance to TNFalpha but not to idarubicin and cytarabine

[year of publication 2008, impact factor 2.901]

Bruchova, H.; Yoon, D.; Agarwal, A.M.; Swierczek, S.; Prchal, J.T.

Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturation

[year of publication 2009, impact factor 2.901]

Fuchs, O.; Kostecka, A.; Provaznikova, D.; Krasna, B.; Brezinova, J.; Filkukova, J.; Kotlin, R.; Kouba, M.; Kobylka, P.; Neuwirtova, R.; Jonasova, A.; Caniga, M.; Schwarz, J.; Markova, J.; Maaloufova, J.; Sponerova, D.; Novakova, L.; Cermak, J.

Nature of frequent deletions in CEBPA

[year of publication 2009, impact factor 2.901]